PSME3IP1
PSME3-interacting protein
Also known as: C16orf94, FAM192A, NIP30, PIP30, PIP30_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZU8
- Gene
- PSME3IP1
- Ensembl
- ENSG00000172775
- Chromosome
- 16
- Canonical length
- 254 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
Involved in negative regulation of proteasomal protein catabolic process. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
254 residues, UniProt reviewed canonical sequence.
>Q9GZU8|PSME3IP1
1 MDGGDDGNLI IKKRFVSEAE LDERRKRRQE EWEKVRKPED PEECPEEVYD PRSLYERLQE
61 QKDRKQQEYE EQFKFKNMVR GLDEDETNFL DEVSRQQELI EKQRREEELK ELKEYRNNLK
121 KVGISQENKK EVEKKLTVKP IETKNKFSQA KLLAGAVKHK SSESGNSVKR LKPDPEPDDK
181 NQEPSSCKSL GNTSLSGPSI HCPSAAVCIG ILPGLGAYSG SSDSESSSDS EGTINATGKI
241 VSSIFRTNTF LEAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSME3IP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 143 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 143 nTPM
- midbrain: 91 nTPM
- testis: 90 nTPM
- tonsil: 90 nTPM
- spleen: 89 nTPM
- spinal cord: 89 nTPM
Single-cell type
- late spermatids: 344 nCPM
- early spermatids: 241 nCPM
- late primary spermatocytes: 198 nCPM
- neutrophils: 163 nCPM
- esophageal apical cells: 124 nCPM
- neutrophil progenitors: 118 nCPM
Immune cell
- basophil: 171 nTPM
- eosinophil: 125 nTPM
- non-classical monocyte: 124 nTPM
- neutrophil: 108 nTPM
- intermediate monocyte: 93 nTPM
- myeloid DC: 90 nTPM
Brain region
- white matter: 159 nTPM
- basal ganglia: 141 nTPM
- medulla oblongata: 139 nTPM
- spinal cord: 132 nTPM
- hypothalamus: 132 nTPM
- midbrain: 131 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0.19
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- FAM192A/Fyv6, N-terminal
- PSME3-interacting protein
- FAM192A/Fyv6, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSME3IP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSME3IP1 as an antibody target. Whether an autoantibody or antibody against PSME3IP1 could matter depends on whether native PSME3IP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSME3IP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PSME3IP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...